drugset / Trial / NCT00969293
Study to Assess the Safety and Tolerability of a Single Administration of FOV2302 (Ecallantide) in Patients With Macular Edema Associated With Central Retinal Vein Occlusion
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the safety and tolerability of a single administration of FOV2302 (ecallantide) in patients with macular edema associated with central retinal vein occlusion.
Timeline
- Start
- 2009-09
- Primary completion
- 2011-07
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FOV2302 | Unknown | 5 ug | Intravitreal |
| Subject | FOV2302 | Unknown | 90 ug | Intravitreal |